Iván Dlouhy

Antibody–Drug Conjugates (ADCs): current and future biopharmaceuticals

Tissue macrophages: origin, heterogenity, biological functions, diseases and therapeutic targets

The outcome of peripheral T-cell lymphoma patients failing first-line therapy: a report from the prospective, International T-Cell Project

High serum levels of soluble interleukin-2 receptor (sIL2-R), interleukin-6 (IL-6) and tumor necrosis factor alpha (TNF) are associated with adverse clinical features and predict poor outcome in diffuse large B-cell lymphoma